![Theranostics best practices](/sites/default/files/styles/hero_background_image_2000x600_/public/2024-08/Theranostics.jpg?itok=p5NF2tEi)
Building a Theranostics Program: Insights and Best Practices for Healthcare Facilities
Theranostics is an exciting and dynamic area of nuclear medicine that combines diagnostic imaging and therapeutic treatment for advanced stage cancer. This approach is particularly appealing because it introduces new challenges and opportunities, ensuring that no two patient cases are alike. Traditional treatments like iodine-131 set the foundation, but recent advancements, such as using lutetium, radium, and other isotopes, have expanded the scope of theranostics.
This short article shares advice from Neil Whiteside, RSO at Yale University, from his Fireside Chat with LANDAUER’s Shawn Pickett. You can listen to the complete conversation here.
Key Considerations for Theranostics Implementation
Implementing theranostics in a healthcare facility requires careful consideration of space, equipment, and staff training. It's essential to have a clear plan for where treatments will take place, who will be involved, and how to handle various operational challenges. For example, the shift from traditional iodine treatments to more complex outpatient infusions requires different workflows and infrastructure, including specialized infusion rooms and lead-lined uptake rooms.
Staying informed about new developments in theranostics is crucial. Attending professional conferences, engaging with peers, and participating in clinical trials are effective ways to keep up with the rapidly evolving landscape. Moreover, when setting up a theranostics program, it's vital to consider not just the immediate needs but also how to scale the program to accommodate a growing patient population.
The role of the Radiation Safety Officer (RSO) is critical in this context, as they must ensure that all safety protocols are followed while supporting the implementation of new treatments. This includes managing contamination risks, preparing for patient readmissions, and ensuring that all team members understand their roles in the treatment process.
As theranostics becomes more prevalent, healthcare facilities must be prepared to adapt their operations, infrastructure, and staffing models to meet the growing demand. This involves planning for potential challenges, such as managing waste, handling contaminated rooms, and addressing regulatory requirements.
In summary, theranostics represents a significant advancement in nuclear medicine, offering new opportunities for personalized treatment. However, it also requires careful planning, collaboration, and a commitment to maintaining safety and regulatory compliance.